查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827814

2025年全球植入式心臟節律器市場報告

Implantable Heart Pacemaker Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式心臟節律器市場穩定成長，從2024年的49.7億美元增加到2025年的51.4億美元，複合年成長率為3.5%。預測期內的成長歸因於心臟照護的進步、人口老化、診斷和篩檢工具的改善、心臟衰竭盛行率的上升、心血管風險因素的增加、臨床研發以及監管支持和核准。

植入式心臟節律器市場規模預計將在未來幾年強勁成長，到2029年將達到64.5億美元，複合年成長率為5.8%。預測期內的成長可歸因於個人化醫療和客製化、新興市場的擴張、對節能設備的關注、對小型化和耐用性的關注、家庭醫療保健解決方案的擴展以及監管發展和標準化。預測期內的主要趨勢包括無線連接和遠端監控、相容MRI的心律調節器、人工智慧 (AI) 整合、智慧型手機連接和應用程式、導線提取技術、遠端醫療整合以及病人參與。

心律調節器是一種植入胸部的小型裝置，可調節心率並防止心率過慢。

植入式心臟節律器有多種類型，包括單腔心律調節器、雙心室節律器和雙心室節律器。單腔心律調節器使用導線連接到心臟的右心房或右心室。它們在醫院、診所和家庭等各種場所使用，用於治療各種疾病，包括心臟傳導阻滯、病竇症候群以及心臟病的診斷。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供植入式心臟心律調節器市場統計數據，例如全球市場規模、區域佔有率、植入式心臟心律調節器市場佔有率競爭對手、詳細的植入式心臟心律調節器細分市場、市場趨勢和商機，以及您在植入式心臟心律調節器行業取得成功所需的數據。本植入式心臟節律器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為5.8%，較我們先前對該市場的預測略有下降0.1%。下降的主要原因是美國與其他國家之間的關稅影響。美國對來自法國和台灣等主要地區的鋰碘電池單元和密封饋通組件徵收關稅，這可能會導致心搏過緩治療的延誤和心律管理成本的增加。

植入式心臟節律器市場的預期成長是由心臟病、糖尿病、高血壓和心房顫動等慢性疾病日益流行的所推動的。慢性病通常持續三個月以上，並且會隨著時間的推移而惡化。植入式心律調節器透過維持規律的心律來解決心率問題，有助於預防和管理心臟病等心臟疾病。例如，根據美國疾病管制與預防中心 2022 年的統計數據，美國約有 3,730 萬人（佔總人口的 11.3%）患有糖尿病。國際糖尿病聯盟報告稱，全球整體約有 5.37 億成年人患有糖尿病，其中四分之三生活在中低收入國家。慢性病的快速成長正在推動對植入式心臟節律器的需求。

醫院對醫療服務日益成長的需求預計將推動植入式心臟心律調節器市場的成長。醫院是專門為病人和傷者提供醫療服務的機構，廣泛使用植入式心臟節律器來管理心臟疾病、調節心律和遠端監控患者。心律調節器對於維持規律的心率和改善患者的生活品質至關重要。例如，根據 Interweave Textiles Limited 的數據，截至 2023 年 8 月，英國共有 1,148 家醫院，其中包括 930 家 NHS 醫院和 218 家私立醫院。醫療服務需求的不斷成長正在推動植入式心臟心律調節器市場的成長。

植入式心臟節律器市場包括體外心律調節器和無導線心律調節器的銷售。此市場的價值是指“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式心臟節律器：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球植入式心臟節律器市場：成長率分析
  • 全球植入式心臟節律器市場表現：規模與成長，2019-2024
  • 全球植入式心臟節律器市場預測：規模與成長，2024-2029年，2034年
  • 全球植入式心臟節律器：總目標市場（TAM）

第6章 市場細分

  • 全球植入式心臟節律器市場：按產品類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單人房
  • 雙腔
  • 兩個房間
  • 全球植入式心臟節律器市場：應用、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 心臟傳導阻滯
  • 病竇症候群
  • 心臟病的診斷
  • 其他用途
  • 全球植入式心臟節律器市場：按最終用戶、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 家
  • 其他最終用戶
  • 全球植入式心臟節律器市場：按單腔、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • VVI（心室需求）
  • AAI（心房需求）
  • 全球植入式心臟節律器市場：按雙腔、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • DDD（雙腔需求）
  • 房室需求（AVD）
  • 全球植入式心臟節律器市場：按雙心室細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • CRT-P（心臟再同步治療-心律調節器）
  • CRT-D（心臟再同步治療-去心房顫動）

第7章 區域和國家分析

  • 全球植入式心臟節律器市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式心臟節律器市場：按國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 植入式心臟節律器市場：競爭格局
  • 植入式心臟節律器市場：公司簡介
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • BIOTRONIK Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • MEDICO SRL Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Vitatron
  • Shree Pacetronix Ltd.
  • Sorin Group
  • Osypka Medical GmbH
  • OSCOR Inc.
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • LivaNova PLC.
  • MicroPort Scientific Corporation
  • Cardioelectronica
  • Hunan Zhongyi Medical Devices Co. Ltd.
  • Shenzhen MicroCor Medical Technology Co .Ltd.
  • Nanjing Normative Biological Technology Co. Ltd.
  • Beijing Huibo Cardiovascular Devices Co. Ltd.
  • Jiangsu Kanghui Medical Devices Co. Ltd.
  • Zhejiang Lewei Medical Instruments Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年植入式心臟節律器市場：提供新機會的國家
  • 2029年植入式心臟節律器市場：細分市場帶來新機會
  • 2029年植入式心臟節律器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22699u

A pacemaker is a small device implanted in the chest to regulate heartbeat, preventing it from slowing down excessively.

Implantable heart pacemakers come in several types such as single-chamber, dual-chamber, and biventricular. The single-chamber pacemaker employs a single lead connected to either the right atrium or right ventricle of the heart. It finds application in treating conditions like heart block, sick sinus syndrome, diagnosing heart diseases, and is utilized across various settings such as hospitals, clinics, households, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable heart pacemaker market research report is one of a series of new reports from The Business Research Company that provides implantable heart pacemaker market statistics, including implantable heart pacemaker industry global market size, regional shares, competitors with an implantable heart pacemaker market share, detailed implantable heart pacemaker market segments, market trends and opportunities, and any further data you may need to thrive in the implantable heart pacemaker industry. This implantable heart pacemaker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable heart pacemaker market size has grown steadily in recent years. It will grow from $4.97 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to advancements in cardiac care, aging population demographics, improved diagnosis and screening tools, increased prevalence of heart failures, rise in cardiovascular risk factors, clinical research and development, regulatory support and approvals.

The implantable heart pacemaker market size is expected to see strong growth in the next few years. It will grow to $6.45 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to personalized medicine and customization, expansion in emerging markets, focus on energy-efficient devices, focus on miniaturization and durability, expansion of home healthcare solutions, regulatory advancements and standards. Major trends in the forecast period include wireless connectivity and remote monitoring, MRI-compatible pacemakers, integration of artificial intelligence (ai), smartphone connectivity and apps, lead extraction techniques, telehealth integration and patient engagement.

The forecast of 5.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on lithium-iodine battery cells and hermetic feedthrough assemblies, sourced from key regions such as France and Taiwan, which could lead to delays in bradycardia treatments and higher expenses for cardiac rhythm management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the implantable heart pacemaker market is attributed to the increasing prevalence of chronic diseases like heart attacks, diabetes, hypertension, and atrial fibrillation. Chronic conditions typically persist for three months or more and may worsen over time. Implantable pacemakers address irregular heartbeats by maintaining a regular cardiac rhythm, aiding in preventing or managing heart diseases like heart attacks. For instance, statistics from the Centers for Disease Control and Prevention in 2022 revealed that around 37.3 million individuals in the United States, equating to 11.3% of the population, suffer from diabetes. Globally, the International Diabetes Federation reported approximately 537 million adults with diabetes, with three-quarters of them in low- and middle-income countries. This surge in chronic conditions is propelling the demand for implantable heart pacemakers.

The increasing demand for healthcare services in hospitals is expected to drive the growth of the implantable heart pacemaker market. Hospitals, specialized facilities providing medical care to the ill or injured, extensively utilize implantable heart pacemakers to manage cardiac conditions, regulate heart rhythm, and monitor patients remotely. They significantly contribute to enhancing patients' overall quality of life by ensuring a consistent and appropriate heart rate. For example, as of August 2023, the UK hosts 1148 hospitals, including 930 National Health Service hospitals and 218 private hospitals, according to Interweave Textiles Limited. This rising demand for healthcare services is fostering the growth of the implantable heart pacemaker market.

Major companies in the implantable heart pacemaker market are prioritizing the development of technologically advanced solutions, including sophisticated cardiac devices, to improve patient outcomes and effectively manage heart conditions. Advanced cardiac devices include a variety of innovative tools, such as leadless pacemakers and cardiac resynchronization therapy devices, designed to optimize heart function. These technologies utilize state-of-the-art materials and software to deliver real-time data and personalized treatment options for patients with heart disease. For example, in November 2023, Abbott Laboratories, a US-based medical device firm, introduced the AVEIR(TM) dual-chamber leadless pacemaker. This device significantly enhances cardiac care by removing complications associated with traditional leads, which are prone to fracturing or infection. Its dual-chamber capability facilitates synchronized pacing of both the atrium and ventricle, thereby improving heart rhythm coordination and patient outcomes.

Major companies in the implantable heart pacemaker market are prioritizing product approvals, such as the dual chamber (DR) leadless pacemaker system, to drive revenue growth. This pioneering technology offers a minimally invasive, leadless solution for patients with slow heart rates. For instance, in July 2023, Abbott Laboratories received FDA approval for the aveir dual chamber (DR) leadless pacemaker system. Utilizing the body's conductive properties, this system delivers low-energy, subthreshold pulses between implanted devices to provide cardiac pacing therapy while sensing intrinsic cardiac signals, marking the first dual-chamber leadless pacemaker.

In November 2022, Johnson & Johnson acquired Abiomed for $16.6 billion, aiming to bolster its position in cardiovascular innovation and improve heart failure care. Abiomed, a company specializing in medical devices that aid heart functions, is now part of Johnson & Johnson MedTech (JJMT), aligning with the healthcare giant's commitment to advancing cardiac care and recovery solutions.

Major companies operating in the implantable heart pacemaker market are Medtronic PLC, BIOTRONIK Inc., Boston Scientific Corporation, Abbott Laboratories, MEDICO SRL, Vitatron, Shree Pacetronix Ltd., Sorin Group, Osypka Medical GmbH, OSCOR Inc., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC., MicroPort Scientific Corporation, Cardioelectronica, Hunan Zhongyi Medical Devices Co. Ltd., Shenzhen MicroCor Medical Technology Co .Ltd., Nanjing Normative Biological Technology Co. Ltd., Beijing Huibo Cardiovascular Devices Co. Ltd., Jiangsu Kanghui Medical Devices Co. Ltd., Zhejiang Lewei Medical Instruments Co. Ltd., Shandong Weigao Medical Devices Co. Ltd., Liaoning Tianma Medical Technology Co. Ltd., Changsha Leadshine Medical Devices Co. Ltd.

North America was the largest region in the implantable heart pacemaker market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable heart pacemaker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable heart pacemaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable heart pacemaker market consists of sales of external pacemakers and leadless pacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Heart Pacemaker Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable heart pacemaker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable heart pacemaker ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable heart pacemaker market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Chamber; Dual Chamber; Biventricular
  • 2) By Application: Heart Block; Sick Sinus Syndrome; Diagnosing Heart Diseases; Other Applications
  • 3) By End User: Hospital; Clinics; House Hold; Other End Users
  • Subsegments:
  • 1) By Single Chamber: VVI (Ventricular Demand); AAI (Atrial Demand)
  • 2) By Dual Chamber: DDD (Dual Chamber Demand); AVD (Atrioventricular Demand)
  • 3) By Biventricular: CRT-P (Cardiac Resynchronization Therapy - Pacemaker); CRT-D (Cardiac Resynchronization Therapy - Defibrillator)
  • Companies Mentioned: Medtronic PLC; BIOTRONIK Inc.; Boston Scientific Corporation; Abbott Laboratories; MEDICO SRL; Vitatron; Shree Pacetronix Ltd.; Sorin Group; Osypka Medical GmbH; OSCOR Inc.; Lepu Medical Technology (Beijing) Co. Ltd.; LivaNova PLC.; MicroPort Scientific Corporation; Cardioelectronica; Hunan Zhongyi Medical Devices Co. Ltd.; Shenzhen MicroCor Medical Technology Co .Ltd.; Nanjing Normative Biological Technology Co. Ltd.; Beijing Huibo Cardiovascular Devices Co. Ltd.; Jiangsu Kanghui Medical Devices Co. Ltd.; Zhejiang Lewei Medical Instruments Co. Ltd.; Shandong Weigao Medical Devices Co. Ltd.; Liaoning Tianma Medical Technology Co. Ltd.; Changsha Leadshine Medical Devices Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Heart Pacemaker Market Characteristics

3. Implantable Heart Pacemaker Market Trends And Strategies

4. Implantable Heart Pacemaker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Heart Pacemaker Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Heart Pacemaker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Heart Pacemaker Market Growth Rate Analysis
  • 5.4. Global Implantable Heart Pacemaker Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Heart Pacemaker Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Heart Pacemaker Total Addressable Market (TAM)

6. Implantable Heart Pacemaker Market Segmentation

  • 6.1. Global Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Chamber
  • Dual Chamber
  • Biventricular
  • 6.2. Global Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart Block
  • Sick Sinus Syndrome
  • Diagnosing Heart Diseases
  • Other Applications
  • 6.3. Global Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Clinics
  • House Hold
  • Other End Users
  • 6.4. Global Implantable Heart Pacemaker Market, Sub-Segmentation Of Single Chamber, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • VVI (Ventricular Demand)
  • AAI (Atrial Demand)
  • 6.5. Global Implantable Heart Pacemaker Market, Sub-Segmentation Of Dual Chamber, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DDD (Dual Chamber Demand)
  • AVD (Atrioventricular Demand)
  • 6.6. Global Implantable Heart Pacemaker Market, Sub-Segmentation Of Biventricular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-P (Cardiac Resynchronization Therapy - Pacemaker)
  • CRT-D (Cardiac Resynchronization Therapy - Defibrillator)

7. Implantable Heart Pacemaker Market Regional And Country Analysis

  • 7.1. Global Implantable Heart Pacemaker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Heart Pacemaker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Heart Pacemaker Market

  • 8.1. Asia-Pacific Implantable Heart Pacemaker Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Heart Pacemaker Market

  • 9.1. China Implantable Heart Pacemaker Market Overview
  • 9.2. China Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Heart Pacemaker Market

  • 10.1. India Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Heart Pacemaker Market

  • 11.1. Japan Implantable Heart Pacemaker Market Overview
  • 11.2. Japan Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Heart Pacemaker Market

  • 12.1. Australia Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Heart Pacemaker Market

  • 13.1. Indonesia Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Heart Pacemaker Market

  • 14.1. South Korea Implantable Heart Pacemaker Market Overview
  • 14.2. South Korea Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Heart Pacemaker Market

  • 15.1. Western Europe Implantable Heart Pacemaker Market Overview
  • 15.2. Western Europe Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Heart Pacemaker Market

  • 16.1. UK Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Heart Pacemaker Market

  • 17.1. Germany Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Heart Pacemaker Market

  • 18.1. France Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Heart Pacemaker Market

  • 19.1. Italy Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Heart Pacemaker Market

  • 20.1. Spain Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Heart Pacemaker Market

  • 21.1. Eastern Europe Implantable Heart Pacemaker Market Overview
  • 21.2. Eastern Europe Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Heart Pacemaker Market

  • 22.1. Russia Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Heart Pacemaker Market

  • 23.1. North America Implantable Heart Pacemaker Market Overview
  • 23.2. North America Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Heart Pacemaker Market

  • 24.1. USA Implantable Heart Pacemaker Market Overview
  • 24.2. USA Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Heart Pacemaker Market

  • 25.1. Canada Implantable Heart Pacemaker Market Overview
  • 25.2. Canada Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Heart Pacemaker Market

  • 26.1. South America Implantable Heart Pacemaker Market Overview
  • 26.2. South America Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Heart Pacemaker Market

  • 27.1. Brazil Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Heart Pacemaker Market

  • 28.1. Middle East Implantable Heart Pacemaker Market Overview
  • 28.2. Middle East Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Heart Pacemaker Market

  • 29.1. Africa Implantable Heart Pacemaker Market Overview
  • 29.2. Africa Implantable Heart Pacemaker Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Heart Pacemaker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Heart Pacemaker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Heart Pacemaker Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Heart Pacemaker Market Competitive Landscape
  • 30.2. Implantable Heart Pacemaker Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. BIOTRONIK Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. MEDICO SRL Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Heart Pacemaker Market Other Major And Innovative Companies

  • 31.1. Vitatron
  • 31.2. Shree Pacetronix Ltd.
  • 31.3. Sorin Group
  • 31.4. Osypka Medical GmbH
  • 31.5. OSCOR Inc.
  • 31.6. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.7. LivaNova PLC.
  • 31.8. MicroPort Scientific Corporation
  • 31.9. Cardioelectronica
  • 31.10. Hunan Zhongyi Medical Devices Co. Ltd.
  • 31.11. Shenzhen MicroCor Medical Technology Co .Ltd.
  • 31.12. Nanjing Normative Biological Technology Co. Ltd.
  • 31.13. Beijing Huibo Cardiovascular Devices Co. Ltd.
  • 31.14. Jiangsu Kanghui Medical Devices Co. Ltd.
  • 31.15. Zhejiang Lewei Medical Instruments Co. Ltd.

32. Global Implantable Heart Pacemaker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Heart Pacemaker Market

34. Recent Developments In The Implantable Heart Pacemaker Market

35. Implantable Heart Pacemaker Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Heart Pacemaker Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Heart Pacemaker Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Heart Pacemaker Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer